The effect of metabolic inhibitors on the production of vaccinia haemagglutinin.
D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002417:Cattle; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D006367:HeLa Cells; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006387:Hemagglutination, Viral; D006389:Hemagglutinins, Viral / Q000037:antagonists & inhibitors*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D011817:Rabbits; D012293:Rifampin / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology; D014616:Vaccinia virus / Q000254:growth & development / Q000378:metabolism
D004279:DNA, Viral; D006389:Hemagglutinins, Viral; D007211:Indoles; D008937:Mitomycins; D013882:Thiosemicarbazones; D005467:Floxuridine; D003561:Cytarabine; D003609:Dactinomycin; D003513:Cycloheximide; D001973:Bromodeoxyuridine; D012293:Rifampin; D006918:Hydroxyurea